Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.35 |
| ▸ | TERT | O14746 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346014 | 0.84 | CTSS (0.47) | CTSSCTSKCASP3CASP7CASP8 | |
| SCHEMBL31345987 | 0.83 | TERT (0.35) | TERTPIK3CAPIK3CBPIK3CGPPARD | |
| SCHEMBL31346005 | 0.77 | ELANE (0.34) | TERTTSHRSMN1; SMN2 | |
| SCHEMBL31346109 | 0.77 | ELANE (0.34) | TERTTSHRSMN1; SMN2 | |
| SCHEMBL31346133 | 0.77 | NPSR1 (0.33) | TERTPPARDCASP3CASP7CASP8 | |
| SCHEMBL31346033 | 0.76 | TERT (0.33) | TERTPIK3CAPIK3CBPIK3CG | |
| SCHEMBL31346039 | 0.75 | SCN10A (0.33) | CTSSPPARD | |
| SCHEMBL31346147 | 0.75 | MRGPRX4 (0.36) | CTSSCASP3CASP7CASP8 | |
| SCHEMBL31346114 | 0.72 | KIF11 (0.36) | — | |
| SCHEMBL31346047 | 0.71 | TEAD1 (0.37) | CASP3CASP7CASP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |